Biofrontera Inc (BFRI) has fallen 4.95% Friday In Premarket Trading

Biofrontera Inc (BFRI) has fallen Friday morning, with the stock decreasing -4.95% in pre-market trading to 4.99. BFRI's short-term technical score of 53 indicates that the stock has traded more bullishly over the last month than 53% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 136 out of 146 industries, BFRI ranks higher than 83% of stocks. Biofrontera Inc has risen 33.93% over the past month, closing at $3.24 on November 5. During this period of time, the stock fell as low as $2.47 and as high as $10.40. BFRI has an average analyst recommendation of Strong Buy. The company has an average price target of $20.00.

BFRI has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on BFRI!

See Full BFRI Report

Biofrontera Inc has a Long-Term Technical rank of 0. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 100% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 142 by this metric, BFRI ranks better than 0% of stocks.

Important Dates for Investors in BFRI:

-Biofrontera Inc is set to release earnings on 2/28/2022. During their last earnings release the company posted EPS of $-0.89. -We do not have a set dividend date for Biofrontera Inc at this time. Click Here To Get The Full Report on Biofrontera Inc (BFRI)